167 related articles for article (PubMed ID: 22520816)
1. Comparative analysis of peptidylarginine deiminase-2 expression in canine, feline and human mammary tumours.
Cherrington BD; Mohanan S; Diep AN; Fleiss R; Sudilovsky D; Anguish LJ; Coonrod SA; Wakshlag JJ
J Comp Pathol; 2012; 147(2-3):139-46. PubMed ID: 22520816
[TBL] [Abstract][Full Text] [Related]
2. Potential role for peptidylarginine deiminase 2 (PAD2) in citrullination of canine mammary epithelial cell histones.
Cherrington BD; Morency E; Struble AM; Coonrod SA; Wakshlag JJ
PLoS One; 2010 Jul; 5(7):e11768. PubMed ID: 20668670
[TBL] [Abstract][Full Text] [Related]
3. Potential role for PAD2 in gene regulation in breast cancer cells.
Cherrington BD; Zhang X; McElwee JL; Morency E; Anguish LJ; Coonrod SA
PLoS One; 2012; 7(7):e41242. PubMed ID: 22911765
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
5. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of E-cadherin and β-catenin in feline mammary tumours.
Zappulli V; De Cecco S; Trez D; Caliari D; Aresu L; Castagnaro M
J Comp Pathol; 2012; 147(2-3):161-70. PubMed ID: 22520821
[TBL] [Abstract][Full Text] [Related]
7. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
8. Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice.
van Beers JJ; Zendman AJ; Raijmakers R; Stammen-Vogelzangs J; Pruijn GJ
Biochimie; 2013 Feb; 95(2):299-308. PubMed ID: 23026755
[TBL] [Abstract][Full Text] [Related]
9. Expression of Cox-1 and Cox-2 in canine mammary tumours.
Queiroga FL; Alves A; Pires I; Lopes C
J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
[TBL] [Abstract][Full Text] [Related]
10. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.
Ishigami A; Ohsawa T; Hiratsuka M; Taguchi H; Kobayashi S; Saito Y; Murayama S; Asaga H; Toda T; Kimura N; Maruyama N
J Neurosci Res; 2005 Apr; 80(1):120-8. PubMed ID: 15704193
[TBL] [Abstract][Full Text] [Related]
11. Subcellular localization of peptidylarginine deiminase 2 and citrullinated proteins in brains of scrapie-infected mice: nuclear localization of PAD2 and membrane fraction-enriched citrullinated proteins.
Jang B; Shin HY; Choi JK; Nguyen du PT; Jeong BH; Ishigami A; Maruyama N; Carp RI; Kim YS; Choi EK
J Neuropathol Exp Neurol; 2011 Feb; 70(2):116-24. PubMed ID: 21343880
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours.
Cassali GD; Gobbi H; Malm C; Schmitt FC
Cytopathology; 2007 Jun; 18(3):191-6. PubMed ID: 17573766
[TBL] [Abstract][Full Text] [Related]
13. Nuclear cytomorphometry in feline mammary gland epithelial tumours.
Simeonov R; Simeonova G
Vet J; 2009 Feb; 179(2):296-300. PubMed ID: 17959399
[TBL] [Abstract][Full Text] [Related]
14. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
15. Tenascin expression in normal, hyperplastic, dysplastic and neoplastic canine mammary tissues.
Faustino AM; van Garderen E; Schalken JA; Nederbragt H
J Comp Pathol; 2002 Jan; 126(1):1-8. PubMed ID: 11814316
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor is expressed in normal canine mammary gland and benign adenomas but decreased in metastatic canine mammary carcinomas similar to human breast cancer.
Klopfleisch R; Hvid H; Klose P; da Costa A; Gruber AD
Vet Comp Oncol; 2010 Dec; 8(4):293-301. PubMed ID: 21062411
[TBL] [Abstract][Full Text] [Related]
17. Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands.
Lee JL; Chang CJ; Wu SY; Sargan DR; Lin CT
Breast Cancer Res Treat; 2004 Mar; 84(2):139-49. PubMed ID: 14999144
[TBL] [Abstract][Full Text] [Related]
18. COX-2 expression in canine normal and neoplastic mammary gland.
Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
[TBL] [Abstract][Full Text] [Related]
19. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
20. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
Millanta F; Citi S; Della Santa D; Porciani M; Poli A
Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]